Published in BMC Fam Pract on May 11, 2010
Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ (2012) 2.66
Accuracy of SIAscopy for pigmented skin lesions encountered in primary care: development and validation of a new diagnostic algorithm. BMC Dermatol (2010) 0.87
Dermoscopy for the diagnosis of melanoma: primary care diagnostic technology update. Br J Gen Pract (2011) 0.79
Point of care cutaneous imaging technology in melanoma screening and mole mapping. F1000Prime Rep (2014) 0.76
The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol (1992) 10.83
Cancer burden in the year 2000. The global picture. Eur J Cancer (2001) 10.47
Designing and evaluating complex interventions to improve health care. BMJ (2007) 9.78
Patients in Europe evaluate general practice care: an international comparison. Br J Gen Pract (2000) 5.91
Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol (2004) 5.49
Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin (1985) 2.57
The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate. Arch Dermatol (2003) 2.12
The UK Government two-week rule and its impact on melanoma prognosis: an evidence-based study. Ann R Coll Surg Engl (2007) 1.75
Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists. J Gen Intern Med (2006) 1.65
Evaluation of the U.K. 2-week referral rule for skin cancer. Br J Dermatol (2004) 1.56
Spectrophotometric intracutaneous analysis: a new technique for imaging pigmented skin lesions. Br J Dermatol (2002) 1.54
The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol (1997) 1.46
The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. Br J Cancer (2007) 1.43
Melanoma incidence and mortality in Scotland 1979-2003. Br J Cancer (2007) 1.41
Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial. Br J Dermatol (2009) 1.32
New MRC guidance on evaluating complex interventions. BMJ (2008) 1.27
Improving primary care residents' proficiency in the diagnosis of skin cancer. J Gen Intern Med (1998) 1.26
Instruments and new technologies for the in vivo diagnosis of melanoma. J Am Acad Dermatol (2003) 1.17
The effectiveness of an Internet-based tutorial in improving primary care physicians' skin cancer triage skills. J Cancer Educ (2002) 1.15
General practitioner screening for melanoma: sensitivity, specificity, and effect of training. J Med Screen (1998) 1.03
Suspected skin malignancy: a comparison of diagnoses of family practitioners and dermatologists in 493 patients. Int J Dermatol (2001) 0.99
Seven-point checklist for melanoma. Clin Exp Dermatol (1991) 0.96
Evaluation of the MoleMate training program for assessment of suspicious pigmented lesions in primary care. Inform Prim Care (2008) 0.96
Assessment of nurse-led screening of pigmented lesions using SIAscope. J Plast Reconstr Aesthet Surg (2007) 0.93
Accuracy of SIAscopy for pigmented skin lesions encountered in primary care: development and validation of a new diagnostic algorithm. BMC Dermatol (2010) 0.87
What features do patients notice that help to distinguish between benign pigmented lesions and melanomas?: the ABCD(E) rule versus the seven-point checklist. Melanoma Res (2005) 0.87
Designing and evaluating complex interventions to improve health care. BMJ (2007) 9.78
Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet (2012) 6.81
Using the Internet to conduct surveys of health professionals: a valid alternative? Fam Pract (2003) 6.31
Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. N Engl J Med (2002) 4.89
A causal modelling approach to the development of theory-based behaviour change programmes for trial evaluation. Health Educ Res (2005) 4.06
Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ (2011) 3.72
British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med (2008) 3.67
Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study. BMJ (2010) 3.44
Improving cancer outcomes: better access to diagnostics in primary care could be critical. Br J Gen Pract (2011) 3.32
Efficacy of a theory-based behavioural intervention to increase physical activity in an at-risk group in primary care (ProActive UK): a randomised trial. Lancet (2008) 2.98
Lay understanding of familial risk of common chronic diseases: a systematic review and synthesis of qualitative research. Ann Fam Med (2004) 2.93
Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ (2012) 2.66
Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. J Acquir Immune Defic Syndr (2010) 2.59
The Andersen Model of Total Patient Delay: a systematic review of its application in cancer diagnosis. J Health Serv Res Policy (2011) 2.59
Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count. AIDS (2007) 2.47
Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice. AIDS (2005) 2.45
A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy. AIDS (2006) 2.35
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS (2014) 2.27
Participating in the United Kingdom Prospective Diabetes Study (UKPDS): a qualitative study of patients' experiences. Br J Gen Pract (2003) 2.25
Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ (2008) 2.25
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012. HIV Med (2012) 2.24
Genetics in general practice. Aust Fam Physician (2014) 2.15
CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis. Genet Med (2005) 2.06
HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era. Eur J Neurol (2010) 2.06
Screening for cardiovascular risk: public health imperative or matter for individual informed choice? BMJ (2002) 1.95
The ADDITION-Cambridge trial protocol: a cluster -- randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients. BMC Public Health (2009) 1.83
Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy. Clin Infect Dis (2012) 1.76
Genetics education for primary-care providers. Nat Rev Genet (2002) 1.73
'Coming down the line'-- patients' understanding of their family history of common chronic disease. Ann Fam Med (2005) 1.68
The DiGEM trial protocol--a randomised controlled trial to determine the effect on glycaemic control of different strategies of blood glucose self-monitoring in people with type 2 diabetes [ISRCTN47464659]. BMC Fam Pract (2005) 1.67
Randomised crossover trial comparing the performance of Clinical Terms Version 3 and Read Codes 5 byte set coding schemes in general practice. BMJ (2003) 1.62
When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studies. AIDS (2003) 1.60
Does electronic monitoring influence adherence to medication? Randomized controlled trial of measurement reactivity. Ann Behav Med (2014) 1.58
Which behavior change techniques are associated with changes in physical activity, diet and body mass index in people with recently diagnosed diabetes? Ann Behav Med (2015) 1.56
HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era. J Clin Oncol (2012) 1.55
Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. J Natl Cancer Inst (2004) 1.55
Randomized controlled trial evaluation of a tailored leaflet and SMS text message self-help intervention for pregnant smokers (MiQuit). Nicotine Tob Res (2012) 1.52
Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial. BMJ (2010) 1.52
The ProActive trial protocol - a randomised controlled trial of the efficacy of a family-based, domiciliary intervention programme to increase physical activity among individuals at high risk of diabetes [ISRCTN61323766]. BMC Public Health (2004) 1.51
Fidelity of delivery of a physical activity intervention: predictors and consequences. Psychol Health (2008) 1.51
Effect of communicating DNA based risk assessments for Crohn's disease on smoking cessation: randomised controlled trial. BMJ (2012) 1.51
Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults. J Infect (2010) 1.49
Achieving compliance with the European Working Time Directive in a large teaching hospital: a strategic approach. Clin Med (2004) 1.49
Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments. J Natl Cancer Inst (2002) 1.48
Improving recruitment to health research in primary care. Fam Pract (2009) 1.47
Development and evaluation of a brief self-completed family history screening tool for common chronic disease prevention in primary care. Br J Gen Pract (2013) 1.45
Primary care referrals for lumbar spine radiography: diagnostic yield and clinical guidelines. Br J Gen Pract (2002) 1.44
The changing pattern of bronchoscopy in an HIV-infected population. Chest (2002) 1.42
Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication. Antivir Ther (2008) 1.41
Theoretical rationale for the use of sequential single-drug antiretroviral therapy for treatment of HIV infection. AIDS (2003) 1.41
Iatrogenic effects of group treatment for antisocial youths. J Consult Clin Psychol (2005) 1.41
Symptoms are highly prevalent among HIV outpatients and associated with poor adherence and unprotected sexual intercourse. Sex Transm Infect (2010) 1.40
What is the effect of a consultant presence in an acute medical unit? Clin Med (2009) 1.39
Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1. Nat Genet (2011) 1.39
What determines Self-Rated Health (SRH)? A cross-sectional study of SF-36 health domains in the EPIC-Norfolk cohort. J Epidemiol Community Health (2010) 1.39
Patient understanding of genetic principles and their expectations of genetic services within the NHS: a qualitative study. Community Genet (1998) 1.36
Impact on patients of expanded, general practice based, student teaching: observational and qualitative study. BMJ (2005) 1.31
Suicidal ideation in UK HIV clinic attenders. AIDS (2008) 1.31
Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. Fam Cancer (2006) 1.30
Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF). Intensive Care Med (2011) 1.30
Data linkage reduces loss to follow-up in an observational HIV cohort study. J Clin Epidemiol (2010) 1.26
Perceptions of family history across common diseases: a qualitative study in primary care. Fam Pract (2006) 1.25
Narrative review: aspirin resistance and its clinical implications. Ann Intern Med (2005) 1.24
Impact of a physical activity intervention program on cognitive predictors of behaviour among adults at risk of Type 2 diabetes (ProActive randomised controlled trial). Int J Behav Nutr Phys Act (2009) 1.24
How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom. Genet Med (2005) 1.24
Survival following HIV infection of a cohort followed up from seroconversion in the UK. AIDS (2008) 1.23
Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2009) 1.23
DNA replication licensing in somatic and germ cells. J Cell Sci (2004) 1.21
Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy. Antivir Ther (2008) 1.21
Physical and psychological symptoms and risk of virologic rebound among patients with virologic suppression on antiretroviral therapy. J Acquir Immune Defic Syndr (2010) 1.20
Harlequin ichthyosis: a review of clinical and molecular findings in 45 cases. Arch Dermatol (2011) 1.18
Long-term trends in adherence to antiretroviral therapy from start of HAART. AIDS (2010) 1.17
Regional variations in prenatal screening across Australia: stepping towards a national policy framework. Aust N Z J Obstet Gynaecol (2006) 1.17
Comparative evaluation of the ExaVir Load version 3 reverse transcriptase assay for measurement of human immunodeficiency virus type 1 plasma load. J Clin Microbiol (2009) 1.15
Impact of body mass index on prevalence of multimorbidity in primary care: cohort study. Fam Pract (2013) 1.13
Treatment switches after viral rebound in HIV-infected adults starting antiretroviral therapy: multicentre cohort study. AIDS (2008) 1.11
Influences on the variation in prevalence of type 2 diabetes between general practices: practice, patient or socioeconomic factors? Br J Gen Pract (2003) 1.11